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Hirschsprung disease (HSCR) is a common congenital disorder that results in intestinal obstruction and lethality,
as a result of defective innervation of the gastrointestinal (GI) tract. Despite its congenital origin, the molecular
etiology of HSCR remains elusive for 170% of patients. Although mutations in the c-RET receptor gene are
frequently detected in patients with HSCR, mutations in the gene encoding its ligand (glial cell line–derived neu-
rotrophic factor [GDNF]), are rarely found. In an effort to establish a possible link between human HSCR and
mutations affecting the Gdnf locus, we studied a large population of mice heterozygous for a Gdnf null mutation.
This Gdnf+/5 mutant cohort recapitulates complex features characteristic of HSCR, including dominant inheritance,
incomplete penetrance, and variable severity of symptoms. The lack of one functioningGdnf allele causes a spectrum
of defects in gastrointestinal motility and predisposes the mutant mice to HSCR-like phenotypes. As many as one
in five Gdnf+/5 mutant mice die shortly after birth. Using a transgenic marking strategy, we identified hypogang-
lionosis of the gastrointestinal tract as a developmental defect that renders the mutant mice susceptible to clinical
symptoms of HSCR. Our findings offer a plausible way to link an array of seemingly disparate features characteristic
of a complex disease to a much more narrowly defined genetic cause. These findings may have general implications
for the genetic analysis of cause and effect in complex human diseases.
Introduction
Hirschsprung disease (HSCR [MIM 142623]) is a com-
mon pediatric disorder, with an incidence of 1/5,000 live
births (Ehrenpreis 1970; Holschneider 1982). The clin-
ical symptoms are vomiting, abdominal distension, se-
vere constipation, and intestinal obstruction, usually
manifested shortly after birth. The main diagnostic cri-
terion is the congenital absence of intrinsic ganglionic
cells (aganglionosis) along the gastrointestinal (GI) tract.
A typical “short segment” aganglionosis, together
with a marked intestinal dilation (megacolon), is ob-
served in the most distal regions of the GI tract. Some-
times, a more proximal “long segment” of the GI tract
is affected as well. Severe intestinal-motility defects, re-
sulting from regional aganglionosis, are incompatible
with life and require surgical removal of the aganglionic
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segment. Occasionally, intestinal sections from patients
with HSCR-like symptoms merely show a reduced num-
ber of ganglionic cells, a condition called hypoganglion-
osis. However, the pathogenesis of hypoganglionosis and
its relationship to HSCR have not been established
(Weinberg 1975; Holschneider 1982; Holschneider et al.
1994; Qualman and Murray 1994). Most patients with
HSCR are infants born to healthy parents, and, in such
cases, the disease appears to be sporadic. Approximately
20% of HSCR cases are familial, defined as more than
one child in the same family affected by the disease. In
familial HSCR, siblings of children with long and short
segment HSCR are expected to develop the disease at a
risk of 8.2%–19.1% and 2.6%–7.6%, respectively; both
risk levels are several hundredfold higher than that of
the general population (0.02%) (Badner et al. 1990).
So far, two signaling pathways have been linked to
HSCR: endothelin 3 (EDN3 [MIM 131242]), with its
receptor endothelin receptor type B (EDNRB [MIM
121244]), and GDNF, with its receptor c-RET ([MIM
164761]; for review, see Kapur 1999). The mutations
in the END3 and EDNRB loci, which account for most
instances of the rare Shah-Waardenburg syndrome
(WS4 [MIM 277580]), are present in !5% of patients
with HSCR (Gershon 1995; Chakravarti 1996). By con-
trast, mutations in c-RET have been observed in as
many as 25% of all patients with HSCR (Edery et al.
1994; Romeo et al. 1994; Yin et al. 1994; Angrist et
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Figure 1 Quantitative analysis of neuronal densities along the GI tracts in adult Gdnf/ and Gdnf/ mice. Gdnf/ mice were crossed
with DbH-nLacZ transgenic mice, to mark enteric neurons in the GI tracts. A, X-gal staining of adult myenteric plexus formations in stomach,
small intestine, and colon. After whole-mount staining, the X-gal–stained outer muscular layer and myenteric plexus were peeled from the rest
of the intestinal wall and were mounted separately on glass slides. Barp 100 mm. B, Neuronal counts per field of myenteric (left) and submucosal
(right) plexi along the GI tracts of adult Gdnf/ and Gdnf/ mice. Average ganglionic cell counts per microscopic field in seven designated
intestinal regions were obtained by counting LacZ-expressing cells at 4# magnification. Four fields were counted in each region of the GI tract.
S p stomach; D p duodenum; C-25 p 25 cm proximal to the cecum (jejunum); C-15 p 15 cm proximal to the cecum (proximal ileum); C-
5 p 5 cm proximal to the cecum (distal ileum); Ce p cecum; Col p colon. Open bar, Gdnf/, animals; filled bar, Gdnf/,Np 6 Np 6
animals. Data in this and all other figures are presented as mean  SEM. * p and ** p , by Student t test.P ! .005 P ! .02
al. 1995; Attie´ et al. 1995). The remaining 170% of
patients with HSCR have not been linked to specific
genetic defects, posing great challenges to our under-
standing of the disease etiology (Puri et al. 1998). Very
few HSCR cases have been associated with mutations
in the gene encoding GDNF, the ligand for c-RET (Angr-
ist et al. 1996; Ivanchuk et al. 1996; Salomon et al.
1996). Biochemical studies have shown that the GDNF
level is reduced in aganglionic segments of the GI tract
(Ba¨r et al. 1997; Martucciello et al. 1998; Ohshiro and
Puri 1998). However, there is no direct genetic evidence
to implicate GDNF as a major susceptibility locus for
human HSCR.
Some animal models have provided insights into the
mechanism of HSCR pathogenesis. Patterns of auto-
somal recessive HSCR are reflected by targeted or spon-
taneous mutations of the EDN3/EDNRB pathway in
mice (Baynash et al. 1994; Hosoda et al. 1994; Puffen-
berger et al. 1994; Edery et al. 1996). These mutant
strains mimic the Shah-Waardenburg syndrome, with
respect to the occurrence of megacolon and distal colon
aganglionosis, the juvenile age at onset, the recessive
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inheritance, the high penetrance of symptoms, and the
presence of associated defects that include depigmen-
tation and deafness (Kusafuka and Puri 1997; Kapur
1999). Mice that lack the function of c-Ret are devoid
of ganglionic cells in the entire GI tract and lack both
kidneys (Schuchardt et al. 1994). Similar phenotypes
are seen in mice with mutations in other components
of the c-Ret pathway, Gdnf and Gfra1 (Moore et al.
1996; Pichel et al. 1996; Sa´nchez et al. 1996; Cacalano
et al. 1998; Enomoto et al. 1998). The studies cited in
the preceding sentence have shown that GDNF/c-RET
signaling pathway is crucial for enteric nervous system
development and kidney organogenesis, but none of the
null mutant mice display genetic features characteristic
of human HSCR. Appropriate animal models for the
common, nonsyndromic HSCR do not yet exist; how-
ever, when they are established, they will improve our
understanding of disease pathogenesis for the dominant
HSCR.
Elsewhere, we have reported a spectrum of abnormal
kidney morphology in a subset of mice that lack one
functioning Gdnf allele (Pichel et al. 1996). We report
here that this mutant cohort is also characterized by
incomplete penetrance and variable expressivity of
Hirschsprung-like intestinal obstruction. As many as
one of every five Gdnf/ mice dies before weaning. Our
study, which involves large cohorts ofGdnfmutant mice
in three different genetic backgrounds, implicates
GDNF as a major HSCR susceptibility locus in humans.
Material and Methods
Animals and Genotyping
Gdnf-null mutant mice were generated as described
elsewhere (Pichel et al. 1996). The mutant mice were
maintained by two to five generations of backcrossing
either into inbred C57BL/6 or 129/Sv strains or into
the outbred CD1 strain. Gdnf/ progeny of these
crosses were mated with DbH-nLacZ/ mice to ob-
tain Gdnf/, DbH-nLacZ/ animals. Primers used for
PCR genotyping were as follows: Gdnf knockout allele
(255 bp; 5′-CGGAGCCGGTTGGCGCTACCGG-3′ and
5′-ACGACTCGGACCGCCATCGGTG-3′); Gdnf wild-
type allele (337 bp; 5′-GAGAGGAATCGGCAGGCTG-
CAGCTG-3′ and 5′-CAGATACATCCACATCGTTTA-
GCGG-3′); and LacZ primer set (278 bp; 5′-ACCCAAC-
TTAATCGCCTTGC-3′ and 5′-AACAAACGGCGGAT-
TGACC-3′.
Quantitative Analysis of Enteric Neuronal Density
Embryonic or adult GI tracts were fixed in 4% para-
formaldehyde at 4C for 0.5–2 h in 0.1M NaPO4 buffer
(pH 7.2) and were washed extensively in X-gal staining
buffer. Whole-mount X-gal staining was performed in
the dark, with freshly prepared X-gal staining solution
(Kapur et al. 1991; Mercer et al. 1991). To obtain ac-
curate neuronal counts in a region-specific manner, we
dissected small segments at defined locations along the
GI tract of adult mice and were mounted the myenteric
and submucosal plexi separately on glass slides. This was
achieved by separating the outer muscular layers, which
contain the myenteric plexus, from the submucosal
plexus and mucosa after X-gal staining. The intestinal
tissues were not stretched during the fixing, staining, or
mounting processes. Duodenum was dissected from
regions caudal to the pyloric junction. Regions of small
intestine were defined on the basis of their relative dis-
tance (in centimeters) from the cecum. The colon speci-
mens were taken from a region of colon that was 4 cm
distal of the cecum. For an accurate quantification of
neuronal density (X-gal–positive nuclear staining) and
for direct comparison of ganglionic cell densities in dif-
ferent regions, four images, under the same magnifica-
tion, were captured per region in each GI tract, using a
CG7-frame grabber with Nikon Microphot microscopy
(Scion). The neuronal density was quantified with an
National Institutes of Health image program.
Genetic Analysis of Mortality in the Preweaning Period
Mortality in the preweaning period was calculated on
the basis of the difference between the number of ex-
pected and the number of observed Gdnf/ offspring,
as determined by genotyping at weaning. Before birth,
Mendelian segregation of Gdnf alleles was well pre-
served (24.2% Gdnf/, 51% Gdnf/, and 24.8%
Gdnf/; ). If we assume equal likelihood ofNp 557
accidental death in the preweaning period for pups of
both the Gdnf/ and the Gdnf/ genotypes, the num-
ber of Gdnf/ weanlings derived from a Gdnf/ #
Gdnf/ cross was expected to be the same as that of
Gdnf/ weanlings. As mentioned before, Gdnf/
mice die at birth. Thus, two-thirds of weanlings de-
rived from a Gdnf/ by Gdnf/ cross were expected
to be Gdnf/, the remaining one-third being wild-type
littermates. The statistical significance of the increased
preweaning mortality of Gdnf/ mice was determined
by x2 analysis.
Results
Significantly Reduced Enteric Innervation in Adult and
Embryonic Gdnf/ GI Tracts
We used a quantitative transgenic marking strategy
to assess the number and mesh density of enteric neu-
rons and to discern subtle differences in the number
of enteric neurons between Gdnf/ and Gdnf/ GI
tracts. Gdnf/ mice were crossed with the DbH-nLacZ
transgenic strain, in which the nuclei of enteric gangli-
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Figure 2 Gdnf gene dosage dependence of enteric innervation in developing mouse embryos. A, Whole-mount X-gal staining of GI tracts
of E11.5 Gdnf/, Gdnf/, and Gdnf/ embryos derived from F2 progeny of Gdnf/ # DbH-nLacZ crosses. e p esophagus; s p stomach;
cp cecum. The blue spots represent individual nuclei of enteric neuronal precursor cells. Note the significant reduction in the number of LacZ-
expressing cells in Gdnf/ and their absence in Gdnf/ stomach (s) and cecum (c), but not in esophagus (e). Barsp 200 mm. B, Whole-mount
immunostaining of E11.5 mid–GI tract explants using anti-neurofilament antibody. Neuronal precursor cells and their processes were visualized
in mid–GI tract explants cultured for 72 h, using a fluorescein-conjugated secondary antibody. Bar p 100 mm. C, Transverse sections of X-
gal–stained GI tracts of E12.5 embryos derived from F2 progeny of a Gdnf/ # DbH-nLacZ/ cross. The number of LacZ-expressing cells
is greatly reduced in the Gdnf/ section. Bar p 50 mm. D, c-Ret in-situ hybridization of transverse sections of E14.5 Gdnf/ and Gdnf/
intestines. The c-Ret mRNA signal is markedly reduced in cells of the myenteric layer of the Gdnf/ section. Bar p 50 mm.
onic cells express the bacterial b-galactosidase reporter
gene under the control of a human dopamine b-hydroxy-
lase gene promoter (Kapur et al. 1991; Mercer et al.
1991). Whole-mount staining of GI tracts provided a
sensitive and quantitative measurement of the density of
the X-gal–targeted enteric ganglionic cells, thereby al-
lowing unambiguous region-by-region comparison of GI
tracts at various ages. Figure 1A shows representative
X-gal staining of myenteric plexus formations of stom-
ach, small intestine, and colon. Quantitative analysis in-
dicated that the numbers, as well as the mesh density,
of ganglionic cells were clearly reduced in both the myen-
teric and the submucosal plexus formations in adult
Gdnf/ GI tracts (fig. 1A and B). In the Gdnf/ GI
tracts, cell numbers were reduced by 64% ( ) inP ! .002
the ileocecum and colon and by 50% in stomach (P !
) and small intestine ( ). Moreover, the weblike.05 P ! .04
connections of myenteric plexi, as well as the cell density
in individual myenteric plexus formations, were severely
diminished in adult Gdnf/ colons (fig. 1A). Thus, there
is a general hypoganglionosis in Gdnf/ GI tracts, and
the terminal intestine may be more sensitive to a reduc-
tion in Gdnf gene dosage.
To define the developmental origin of hypoganglion-
osis of Gdnf/ animals, we performed X-gal staining of
embryonic GI tracts. Gdnf gene dosage-dependent dif-
ferences in the number of X-gal–positive cells were de-
tected as early as embryonic day (E) 10, as soon as the
migrating enteric precursor cells arrive in the developing
stomach (data not shown). At E11.5, extensive X-gal–
positive cells reached the ileocecal junction in Gdnf/
embryos (fig. 2A). Consistent with previous findings
that enteric neuronal precursors of both vagal and
sacral crest origins are defective in the absence of
GDNF (Durbec et al. 1996; Pichel et al. 1996), few,
if any, X-gal–positive cells were present beyond the
esophagus in the Gdnf/ intestine (fig. 2A). Signifi-
cantly, X-gal staining revealed a reduction in the density
of the enteric precursors in Gdnf/ mutants (fig. 2A and
C). As a consequence, fewer neuronal processes, as re-
vealed by whole-mount antineurofilament immunostain-
ing, were present in Gdnf/ intestines as compared with
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Figure 3 Spectrum of intestinal-motility defects in adult Gdnf/ mice. A, Examples of intestinal-motility defects. GI tracts dissected from
a Gdnf/ mouse, a Gdnf/ mouse with fecal retention but normal stomach (Gdnf/[s]), and a Gdnf/ mouse with severe fecal retention and
stomach distention [Gdnf/(S)]. smi p small intestine; col p colon. B, Association of colon dilation with other deficits in the Gdnf/ cohort.
The severity of the colon dilation is defined qualitatively: Grade 1 p small to mild dilation, 1.3–2.0# the width of the Gdnf/ colon; Grade
2 p severe colon dilation, 12# the Gdnf/ colon width. Stomach distention is defined as 11.5# the normal Gdnf/ stomach size after 2–6
h of fasting (as marked by “S” in panel A). Fecal retention is defined as (1) a greatly increased number of fecal pellets, in comparison with the
number seen in the Gdnf/ control or (2) a continuous string of pellets along the length of the large intestine. The percentage of animals with
stomach distention or fecal retention was calculated for animals with grade 1 or 2 colon dilation, respectively, and was also noted in a small
fraction (!5%) of control mice. C, Average weight of stomachs derived from Gdnf/ ( ), Gdnf/(s) ( ), and Gdnf/(S) (Np 28 Np 27 Np
) mice. * p (Student t test).30 P ! .0001
those in Gdnf/ controls (fig. 2B). In parallel, there was
a reduced density of c-Ret expressing cells, as visualized
by in situ hybridization (fig. 2D). Taken together, these
results underscore the quantitative effect of Gdnf sig-
naling on the development of c-Ret–expressing enteric
precursors and suggest an anatomical and pathogenetic
basis for HSCR susceptibility in Gdnf/ mice.
Significantly Compromised Intestinal Motility in Adult
and Newborn Gdnf/ Mice
To determine whether hypoganglionosis causes func-
tional impairment in adult Gdnf/ mice, we examined
172 adult animals (37 Gdnf/ and 135 Gdnf/) for
possible defects in intestinal motility. The Gdnf/ GI
specimens revealed varying degrees of colon dilation
(84%), fecal retention (74%), and stomach distention
(38.5%). In contrast, !5% of the GI tracts dissected
from Gdnf/ animals showed stomach distention or fe-
cal retention. The high percentage of mice with fecal
retention, a sign of chronic constipation, correlates well
with greater reduction of neuronal counts at the terminal
intestine. The normal GI tract (fig. 3A) shows discretely
segregated fecal pellets that result from a propulsive in-
testinal movement controlled by intrinsic enteric neu-
ronal circuits (Gershon et al. 1994; Milla 1996). The
efficiency of movement was apparently impaired in
Gdnf/ mutants, because fecal retention, especially in
the colon, was very common (fig. 3A). Stomach disten-
tion was less common and was often accompanied by
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more-severe fecal retention and a backup of processed
food into a substantial portion of the small intestine (fig.
3A). We graded the degree of colon dilation semiquan-
titatively, assigning values as follows: grade 0 indicates
no dilation, Gdnf/ colon width; grade 1 indicates
small-to-moderate dilation, 1.3–2 times as great as that
of Gdnf/ colon width; and grade 2 indicates severe
colon dilation, i.e., 12 times that ofGdnf/ colon width.
In Gdnf/ mice, an increase in stomach size was often
associated with grade 2 intestinal dilation (fig. 3B and
C). Taken together, our observations strongly suggest a
causal relationship between a loss of a functional Gdnf
allele and the presence of hypoganglionosis and wide-
spread intestinal dysmotility in the adult Gdnf/
cohorts.
To evaluate a possible clinical manifestation of im-
paired intestinal innervation in younger Gdnf/ mice,
we noninvasively assessed functional consequences of
hypoganglionosis in newborn mice. We recorded the
time interval between last feeding and the disappearance
of the “milk spot” (i.e., milk-filled stomach readily vis-
ible through the skin of the neonate). This time interval
was 20  4 h in Gdnf/ mutants ( ), and 5  1Np 8
h in Gdnf/ littermates ( ). The delayed gastricNp 5
emptying in newborn Gdnf/ mutants suggests that en-
teric hypoganglionosis causes impaired intestinal motil-
ity at birth, consistent with the developmental origin of
hypoganglionosis. The varying severity of intestinal dys-
motility points to a clinical predisposition to HSCR-like
symptoms in the Gdnf/ cohort.
Severe Hypoganglionosis and/or Segmental
Aganglionosis in Gdnf/ Mice
Human HSCR is based on segmental aganglionosis
that is typically observed in the distal colon (Ehrenpreis
1970; Holschneider 1982). To determine whether an
HSCR-like pathology could exist in the Gdnf/ cohort,
we focused on the density of ganglionic cells in the GI
tracts of the mutant mice. In our experiments, we defined
aganglionosis as an absence of—and hypoganglionosis
as a reduction in—the number of X-gal staining cells.
We examined a large number of mice—at various stages
of life, from neonatal to adulthood—for variations in
enteric innervation. In adult Gdnf/ GI tracts, we not
only found a general reduction in the number of X-
gal–positive cells, but we also frequently observed in-
testinal segments, of variable length, that were entirely
devoid of them (see the example shown in fig. 4A). These
seemingly aganglionic regions were interspersed along
the hypoganglionic regions of the intestine (fig. 1A).
Aganglionosis was never observed in Gdnf/ GI tracts.
However, figure 4A shows a rare example of hypogan-
glionosis in a Gdnf/ intestine. Regional variation of
neural density occurs in both Gdnf/ and Gdnf/ GI
tracts. Such a variation may explain why we saw regions
almost devoid of X-gal staining in predominantly hy-
poganglionic Gdnf/ mice (fig. 4C) and occasional hy-
poganglionosis in normal animals (fig. 4B). Thus, re-
gional aganglionosis, which is most commonly found in
the small intestines, occurs in adult Gdnf/ mice that
do not have HSCR.
In human pathology, the diagnosis of HSCR is based
on the absence of ganglionic cells (aganglionosis) from
serial sections of intestinal biopsies. Hypoganglionosis
in the context of HSCR is rarely documented by this
procedure. To better relate our whole-mount X-gal stain-
ing results to those obtained by serial sections of human
intestinal tissue, we examined transverse sections of
Gdnf/ mutant intestinal specimens. We found signifi-
cantly more aganglionosis than hypoganglionosis in
Gdnf/ intestinal specimens. Fig. 4D shows an example
of seemingly aganglionic or severely hypoganglionic pa-
thology in a transverse Gdnf/ colon section, compared
with a wild-type control. The very few enteric neurons
in the Gdnf/ colon section shown here could be easily
missed were they not marked by X-gal staining. The
peeled myenteric spreads (figs. 4B and 4C) that we used
as a basis for the assessment of ganglionic density are
∼1 mm, which is equivalent to 2% of the length of an
adult mouse colon. This amounts to ∼200 consecutive
5-mm intestinal sections, as shown in figure 4D. It fol-
lows that a distinction between severe hypoganglionosis
and aganglionosis, based on the examination of a limited
number of cross sections of intestinal tissue, is difficult
to make. Thus, hypoganglionosis in the context of a
variety of intestinal dysmotility and HSCR may be much
more widespread than has hitherto been recognized.
Low Penetrance of Early-Onset Lethality in the Gdnf/
Cohort
Severe hypoganglionosis and aganglionosis were
also observed in some of the X-gal-stained newborn
Gdnf/ intestinal specimens. Figure 5C shows an ex-
ample of a peeled myenteric plexus from a newborn
Gdnf/ mouse in which approximately half of the entire
GI tract was aganglionic and the rest severely hypogan-
glionic, compared to whole-mount X-gal staining of GI
tracts from Gdnf/ and Gdnf/ controls shown in fig-
ures 5A and 5B. Mice with such severe aganglionosis
are unlikely to survive. In human HSCR, segmental
aganglionosis causes intestinal obstruction, and, if un-
treated, most patients with HSCR die within the first
year of life. Treatments include temporary relief of ob-
struction by repeated enema and, ultimately, by surgical
removal of aganglionic GI segments. High mortality
(67%) is associated with long-segment HSCR, regardless
of treatment (Badner et al. 1990; Berry and Keeling 1996).
In an effort to determine whether a severe reduction
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Figure 4 Enteric hypoganglionosis and aganglionosis in adult Gdnf/ mice revealed by X-gal staining in whole-mount preparations and
on sections. A, Regional variation of X-gal–stained ganglionic cell density in adult Gdnf/ and Gdnf/ GI tracts. Left, an occasional and
limited hypoganglionic segment in a Gdnf/ intestine (arrow) flanked by normal ganglionosis (arrowhead). Bar p 1 mm. Right, a portion of
segmental aganglionosis in Gdnf/ small intestine. B, Normal and hypoganglionic myenteric plexus of the small intestine from an adult Gdnf/
mouse. Bar p 100 mm. C, Hypoganglionic and almost aganglionic myenteric plexus of the small intestine from an adult Gdnf/ mouse. Bar
p 100 mm. D, X-gal–stained transverse sections through a P17 Gdnf/ colon (normal ganglionic) and a P17 Gdnf/ colon (aganglionic).
Arrowheads indicate X-gal positive ganglionic cells. Bar p 20 mm.
in enteric ganglion density can result in early-onset
lethality in our mutant mice as well, we examined
whether there is a preferential loss of Gdnf/ mice
prior to weaning. Up to the date of birth, Mendelian
segregation of Gdnf alleles was well preserved (24.2%
Gdnf/, 51% Gdnf/, and 24.8% Gdnf/ [Np
]). As reported above, nearly all animals that died557
within the first 24 h were homozygous Gdnf-null mu-
tants (Moore et al. 1996; Pichel et al. 1996; Sa´nchez
et al. 1996). Nearly all pups that died after the first
24 h were Gdnf/. Neither Gdnf/ nor Gdnf/ pups
that were found dead exhibited gross signs of GI di-
lation. The extent of Gdnf/ lethality in the pre-
weaning period was calculated on the basis of the
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Figure 5 Preweaning lethality in Gdnf/ population by pathological and genotyping analysis A, Overview of myenteric plexus from a
Gdnf/ newborn mouse. Barp 1 mm. B, Overview of myenteric plexus from a Gdnf/ newborn mouse. esp esophagus; sip small intestine;
cep cecum; and colp colon. Barp 1 mm. C, Example of extensive aganglionosis and severe hypoganglionosis in a newborn Gdnf/ mouse.
Shown here are the pieces of myenteric plexus peeled from the GI tract of a single newborn Gdnf/ mouse after whole-mount X-gal staining;
a p aganglionosis. Bar p 1 mm. D, Preweaning lethality in Gdnf/ population. Preweaning mortality p [the number of expected Gdnf/
mice  the number of observed Gdnf/ offspring at weaning]/total number of expected births (on the basis of genotyping at weaning). The
expected number of Gdnf/ mice is equal to Gdnf/ in Gdnf/ # Gdnf/ crosses (twice the wild-type number in Gdnf/ # Gdnf/ crosses).
Mating schemes and names of strains used in the crosses are listed in the figure. CD1 is an outbred strain, and B6 (C57BL/6) and 129 (129/
Sv) are two inbred strains.
numerical difference between observed and expected
Gdnf/ genotypes at weaning. Our results show that
a low, but highly significant, preweaning lethality is
associated with Gdnf heterozygosity (fig. 5D).
We determined the influence of genetic background
on the penetrance of the lethal phenotype using two
different mating schemes. The preweaning lethality was
8.4% when the mutant Gdnf allele was maintained in
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an outbred CD1 strain (Gdnf/ # Gdnf/; ,Np 962
) (fig. 5D), and it increased to 17.1% when theP ! .01
mutant Gdnf allele was backcrossed to the inbred
C57BL/6 strain (Gdnf/ # Gdnf/; ,Np 207 P !
; fig. 5D). Moreover, interbreeding of Gdnf/ off-.001
spring from the outbred CD1 strain, but not from
C57BL/6 or 129/Sv background, resulted in a significant
increase (from 8.4% to 16.7%) in overall mortality for
the CD1 strain ( ), and a loss of strain-dependentP ! .05
difference in mortality (16.7%–24.7%, , 112,Np 805
104, respectively; , fig. 5D). The sex ratio for theP 1 .5
surviving 80%–90% Gdnf/ mice remained at 1:1, sug-
gesting a lack of sex bias on lethality in the Gdnf/
cohort. We noted unilateral kidney agenesis in ∼10% of
our Gdnf/ animals, confirming our earlier observation
(Pichel et al. 1996). However, pathological examination
failed to establish kidney dysfunction as the cause of
death. Rather, our results support the notion that a sub-
population of theGdnf/ mice is predisposed to develop
segmental aganglionosis and severe hypoganglionosis
that are incompatible with life. Increased homozygosity
at modifier loci may well influence the mortality rate.
Discussion
Our study of mice that are heterozygous for a null mu-
tation in the GDNF gene has uncovered defects in enteric
innervation and intestinal motility and a low, but highly
significant, incidence of postnatal death. The phenotype
of these mice reflects important aspects of Hirschsprung
disease, in particular those seen in patients who carry
mutations in components of the c-RET signaling path-
way. There is a close resemblance among major param-
eters, including inheritance pattern, penetrance, expres-
sivity, and age at onset of symptoms. The apparent
phenotypic complexity revealed by our analysis of these
mutant mice is based on Gdnf haploinsufficiency. Our
results provide direct genetic evidence linking the Gdnf
locus to HSCR etiology.
We assessed in different ways the possibility that a
defined genetic defect affecting Gdnf gene dosage could
elicit a broad spectrum of anatomical changes and dis-
ease symptoms that are typical of human HSCR. First,
we examined the phenotypic consequences of a lack of
one functioning Gdnf allele in several genetic back-
grounds. The results suggested to us an involvement of
second-site modifiers. Second, to study disease suscep-
tibility, we used a population genetics approach, ex-
amining phenotypic variations in a large cohort of mu-
tant mice. Third, in an effort to understand the apparent
low penetrance and sporadic occurrence of HSCR in
human patients, we employed an enteric ganglion–
marking strategy to distinguish susceptible individuals
from nonsusceptible ones in our mouse mutant cohorts
and to diagnose the disease objectively. We took the
following precautions to ensure that the difference in
ganglionic cell density accurately reflects Gdnf gene
function, rather than random fluctuation of X-gal stain-
ing. (1) The neuronal density and plexus pattern were
independent of the copy number of the LacZ transgene
(data not shown) but were dependent on Gdnf gene
dosage. (2) Gdnf/ and Gdnf/ GI tracts were derived
from the same litters and were stained at the same time.
(3) The change in enteric density along the GI tract
correlated well with the density of c-Ret–expressing
cells. (4) The same staining of the X-gal–positive cells
of Gdnf/ intestinal specimens that exhibited regional
aganglionosis also showed a general hypoganglionosis.
In contrast, aganglionosis was never observed in Gdnf/
 control animals.
The low incidence and the variable severity of dis-
ease phenotypes are addressed in the model of figure
6. The model is based on the current state of knowl-
edge with regard to neural crest innervation of the
vertebrate GI tract (Burns and Le Douarin 1998, and
references cited therein) and on our observations on
Gdnf/ and Gdnf/ mutant mice. In the schematic
drawing, we compare embryonic GI tract innervation
in four scenarios: (1) Gdnf/, (2) Gdnf/ with an
asymptomatic phenotype (defined here as non-lethal),
(3) Gdnf/ with a lethal phenotype, and (4) Gdnf/.
The presence of neuronal precursors derived from the
neural crest is indicated by dots, the relative frequency
of which depends on the genotype and the position
along the GI tract. Vagal neural crest cells innervate the
entire GI tract. Crest cells derived from the anterior
trunk region colonize the esophagus and the proximal
part of the stomach, and sacral neural crest cells con-
tribute mostly to the innervation of the terminal intes-
tine. Enteric ganglionic cells, which are missing in mice
that are homozygous for mutations in components of
the c-Ret signaling pathway, are derived from vagal and
sacral neural crest precursor cells. By contrast, cells de-
rived from the anterior trunk region are retained in
those mutants (see the diagram labeled “Gdnf/” in
fig. 6). Precursor-cell density is highest in the distal-
most part of the intestine, with dual contributions
from both vagal and sacral crest, possibly reflecting
special functional requirements in this area of the GI
tract (Ehrenpreis 1970). It is precisely here that we
see the greatest variability in the degree of hypogan-
glionosis in our Gdnf/ mutant animals. While all
Gdnf/ animals are hypoganglionic when compared
with the Gdnf/ control, the observed spread in gan-
glionic cell counts of the distal GI tract correlated
directly with the variable expressivity of intestinal
dysmotility defects. A limited reduction in ganglionic
cell density will be asymptomatic, as indicated in the
diagram “Gdnf/(a)” in figure 6. However, below a
certain threshold level of distal intestinal innervation,
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Figure 6 Schematic drawing of enteric innervation in normal and Gdnf mutant mice. This model addresses the incomplete penetrance
and variable expressivity of symptoms resulting from Gdnf haploinsufficiency. The drawing on the left shows the migration paths of neural
crest cells (enteric neuronal precursors) emanating from the dorsal midline at the time of neural-tube closure. Numbers indicate somite positions.
Dots in the four drawings to the right are color coded according to the respective migration routes. They mark the position of neuronal precursors
of late-gestation embryos along the GI tract. Vagal neural crest cells (red, somite 1–7) innervate the entire GI tract. Crest cells derived from
the anterior trunk region (blue) colonize the esophagus and the proximal part of the stomach, and sacral crest cells (green, beyond somite 28)
contribute to the innervation of the post-umbilical colon. The density and distribution of dots in the four drawings to the right reflects the
neuronal counts obtained in normal and mutant mice. Gdnf/ p Gdnf/ control; Gdnf/(a) p asymptomatic Gdnf/; Gdnf/(l)p lethal
Gdnf/; and Gdnf/ p Gdnf-null mutants. Bracketed regions in Gdnf/(l) represent aganglionic segments, suggesting a further reduction of
neuronal density from the level of asymptomatic Gdnf/(a) control. E p esophagus; S p stomach; Sm Int p small intestine; Ce p cecum;
Col p colon.
lethal intestinal obstruction will ensue. Such a situation
is depicted in the diagram “Gdnf/(l)” in figure 6. We
suggest that similar scenarios may play out in human
HSCR, in which the degree of hypoganglionosis may
well be a crucial determinant of the ensuing disease
phenotype. Our results have shown that whole-mount
staining techniques, presently not available in human
pathology, are required to properly assess the levels of
ganglionic cell density.
Burns and Le Douarin (1998) have discussed and
referenced in detail findings in support of an inter-
action between vagal and sacral crest cells during col-
onization of the hindgut of both avian and mam-
malian embryos. Furthermore, their study of chick/
quail chimeras directly demonstrates that sacral crest
cells indeed contribute to terminal intestinal inner-
vation. The present study, as well as findings published
elsewhere (Schuchardt et al. 1994; Durbec et al. 1996;
Moore et al. 1996; Pichel et al. 1996; Sa´nchez et al.
1996; Cacalano et al. 1998; Enomoto et al. 1998), in-
dicate that a functional c-Ret signaling pathway is oblig-
atory for GI tract innervation by both vagal and sacral
crest derivatives, because all neuronal cells are missing
from the intestine of c-Ret, Gdnf, and Gfra1 homo-
zygous null mutants. In mice, no markers are presently
available that would distinguish enteric neuronal pre-
cursors derived from the vagal crest from those of sacral
crest origin. In Gdnf/ mice, we see a disproportional
loss and a high variability in the number of DbH-
LacZ–positive cells in the distal-most part of the intes-
tine, suggesting that the sacral crest derivatives are more
likely to be affected by the loss of a functioning Gdnf
allele than are cells derived from the vagal crest. On the
basis of these considerations, our model in figure 6 pos-
tulates that the sacral crest contributes to post-umbilical
intestinal innervation in the mammalian embryo as well.
Migration of sacral crest–derived cells to the postum-
bilical intestine is independent of vagal crest cell mi-
gration, as demonstrated by previous lineage-tracing
studies (Pomeranz and Gershon 1990; Pomeranz et al.
1991; Serbedzija et al. 1991). However, further devel-
opment of sacral crest–derived enteric precursors into
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Table 1
Genetic Features of Patients with HSCR and in Gdnf+/5 Mice
Characteristic Patients Mice
Inheritance pattern Dominant (c-RET mutations) Dominant (Gdnf)
Penetrance Incomplete Incomplete
Expressivity Variable Variable
Time of onset Shortly after birth Before weaning
Frequency of occurrence Predominantly sporadic Predominantly sporadic
Associated defects Urinary and kidney defects Kidney dysgenesis
Sex bias (M:F) Short segment (4:1), long segment (1:1) None (1:1)
Modifier effect Multigenic and heterogeneous Dependent on genetic background
Risk to siblings 2.6%–7.6% (short segment),
8.2%–19.1% (long segment)
8.4%–17.1% (before weaning)
enteric neurons may well depend on signals from cells
derived from the vagal crest. Thus, a limited variation
in the number of vagal crest–derived progenitors that
manage to reach the Gdnf/ terminal intestine may
trigger an amplified and nonlinear innervation response
by sacral crest precursors. This could explain why the
number of ganglionic cells is reduced nowhere so much
as in the colon of Gdnf/ animals.
Our study shows that loss of a functioningGdnf allele
can lead to severe hypoganglionosis and segmental
aganglionosis along the GI tracts of affected offspring.
Any mutation that reduces the number of neurons that
control intestinal motility has the potential of causing
dysmotility and its clinical consequences. This is espe-
cially true for the large intestine, where, according to
our results, the maintenance of a threshold level of mus-
cle innervation seems critical. Severe hypoganglionosis
in the terminal intestine may be less tolerable than
segmental aganglionosis of more proximal regions of
the GI tract. This may explain why a high proportion
of the Gdnf/ mice exhibit clinical symptoms involving
the colon (84% of the adult mice exhibit varying de-
grees of colon dilation, and 74% show fecal reten-
tion). It is important to note that the diverse intestinal
dysmotility presentations are mediated by a single ge-
netic defect. This knowledge may prove to be useful in
genetic screening and counseling of families at risk of
human HSCR.
There has been a long-standing uncertainty as to
whether enteric hypoganglionosis, in addition to the
well-recognized aganglionosis of the terminal intes-
tine, may be an essential part of the pathogenesis of
HSCR and related disorders (Ehrenpreis 1970). Our
mouse data suggest that this is indeed the case. However,
a quantitative analysis of neuronal counts along the GI
tract of patients with HSCR, on the basis of whole-
mount staining techniques, is difficult to achieve.
Rather, clinical diagnosis is commonly based on the
evaluation of a limited number of randomly selected
intestinal sections. This approach is unlikely to properly
assess varying degrees of hypoganglionosis, because of
the normal fluctuation in neuronal density along the GI
tract (Karaosmanoglu et al. 1996; Szabolcs et al. 1996,
and the present study). Therefore, verification of general
hypoganglionosis, especially if not accompanied by seg-
mental aganglionosis, will remain problematic (Kapur
1999). It follows that general enteric hypoganglionosis
and its underlying genetic causes may be much more
widespread in the human population than can be es-
timated by current medical diagnosis. Our results sug-
gest that, in addition to segmental aganglionosis, se-
vere hypoganglionosis is likely an integral mechanism
to human HSCR pathogenesis and susceptibility. In par-
ticular, our experiments may help to understand the
pathogenesis of HSCR in patients who carry mutations
in the c-RET pathway, because many characteristics of
their disease (as reviewed by Pasini et al. [1996]) are so
well reflected by our mouse model (table 1).
Despite the paucity of Gdnf mutations associated
with human HSCR, several features of our animal
model, as listed in table 1, draw attention to reduced
GDNF function as a possible cause. Phenotypic features
of our Gdnf/ mice are dominantly inherited and show
an incomplete penetrance, thereby reflecting a main
characteristic of prevalent forms of dominant human
HSCR. In addition, there are strong parallels with re-
gard to onset and severity of symptoms. Furthermore,
a reduced GDNF level has been associated with loss of
ganglionic cells in the GI tracts of patients with HSCR
(Ba¨r et al. 1997; Martucciello et al. 1998; Ohshiro and
Puri 1998). Yet, Gdnf/ mice do not exhibit megaco-
lon, and they lack the sex bias. Both megacolon and
sex bias are hallmarks of short-segment human HSCR.
Rather, their phenotype resembles the more severe
form of long-segment HSCR—possibly because, in
both cases, extensive loss of enteric neurons along the
GI tract extends proximally into the small intestine.
Third, the penetrance of the perinatal mortality in the
Gdnf/ mutants is strikingly similar to sibling risk in
familial cases of human long-segment HSCR. Regard-
less of whether the similarity is significant or merely
coincidental, it underscores the notion that the obser-
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vation of complex phenotypes is compatible with the
presence of a defined genetic lesion in a single locus.
Obviously, Gdnf haploinsufficiency, without concomi-
tant mutations in the coding sequence, is sufficient to
cause a spectrum of mild-to-severe phenotypes that are
based on varying degrees of hypoganglionosis and seg-
mental aganglionosis. We reason that subthreshold lev-
els of GDNF would result in ganglion loss to a degree
incompatible with normal intestinal function and would
be followed by clinical symptoms of HSCR.
On the basis of a population study of 2,000 Gdnf/
mice in three genetic backgrounds, we find that as many
as 90% of these mutant animals are in a susceptible
state. They are more likely than are wild-type mice to
produce offspring that develop HSCR, with a low but
significant incidence of postnatal death in the various
Gdnf/ cohorts. This allowed us to assess susceptibility
to a complex disease, a fundamental issue that is not
easily amenable to genetic evaluation in humans. Taken
together, our results suggest that the Gdnf locus may
be more frequently associated with human HSCR than
has hitherto been realized, whether through mutations
in the GDNF gene itself or in any other gene that affects
GDNF signaling efficacy. Our findings offer a plausible
way to connect an array of seemingly disparate features
that are characteristic of a complex disease to a much
more narrowly defined genetic cause. The lessons we
learned in linking a low penetrance of symptoms to
disease susceptibility demonstrate that a broad-based
population study in genetically defined mutant strains
can be an effective alternative approach to the dissection
of the genetic basis of complex human disorders (Bedell
et al. 1997a, 1997b; Justice 2000).
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